| 摘要 |
<p>The present invention provides compositions for inactivating thrombin bound to fibrin within a thrombus or clot, whereby the ability of clot-bound thrombin to catalytically promote further clot accretion is substantially diminished or eliminated. The compositions of the present invention are particularly useful for preventing thrombosis in the circuit of cardiac bypass apparatus and in patients undergoing renal dialysis, and for treating patients suffering from or at risk of suffering from thrombus-related cardiovascular conditions, such as unstable angina, acute myocardial infarction (heart attack), cerebrovascular accidents (stroke), pulmonary embolism, deep vein thrombosis, arterial thrombosis, etc. The compositions comprise agents which activate heparin cofactor II mediated inhibition of thrombin and having minimal affinity for antitrhombin III. Preferred agents are low molecular weight heparin preparations (MW of 3,000-8,000) prepared by depolymerising heparin using nitrous acid, oxidising the resultant product with periodate and reducing it with borohydride. The product has its non-sulphated uronic acid residues in open ring form and it substantially free of aldehyde groups.</p> |
